Profile data is unavailable for this security.
About the company
Arctic Bioscience AS is a Norway-based biotech company developing and commercializing both pharmaceutical and nutraceutical products based on the properties of herring roe oil. Arctic Bioscience’s purpose is to provide people with autoimmune disorders an effective and healthy therapy based on marine membrane lipids. The Company is developing HRO350 - a novel investigational drug candidate. HRO350 is being developed for treatment of patients with mild-to-moderate psoriasis. The Company's product portfolio includes, among others, Romega, which is a producer of an omega-3 dietary supplement made from herring roe in a form of a capsule, as well as herring caviar oil and herring caviar protein offered to Business-to-Business (B2B) customers. Arctic Bioscience AS has three subsidiaries Arctic Nutrition AS, Romega AS and Arctic Biopharma AS.
- Revenue in NOK (TTM)23.95m
- Net income in NOK-36.30m
- Incorporated2011
- Employees--
- LocationArctic Bioscience ASIndustrivegen 42ORSTA 6155NorwayNOR
- Websitehttps://arctic-bioscience.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cereno Scientific AB | 0.00 | -19.04m | 225.63m | -- | -- | 1.46 | -- | -- | -0.1988 | -0.1988 | 0.00 | 1.50 | 0.00 | -- | -- | -- | -13.47 | -18.58 | -15.50 | -20.82 | -- | -- | -- | -- | -- | -18.99 | 0.0326 | -- | -- | -- | -1.48 | -- | 54.51 | -- |
| Hamlet Pharma AB | 0.00 | -9.88m | 232.28m | 4.00 | -- | 8.87 | -- | -- | -0.0928 | -0.0928 | 0.00 | 0.3709 | 0.00 | -- | -- | -- | -37.15 | -78.57 | -45.89 | -95.01 | -- | -- | -- | -- | -- | -32.45 | 0.00 | -- | -- | -- | 67.05 | -- | -- | -- |
| AlzeCure Pharma AB | 0.00 | -72.09m | 240.94m | 14.00 | -- | 5.71 | -- | -- | -1.76 | -1.76 | 0.00 | 0.8461 | 0.00 | -- | -- | 0.00 | -106.78 | -- | -127.49 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -8.99 | -- | -- | -- |
| Lipidor AB | 15.01m | -27.87m | 242.18m | -- | -- | 10.37 | -- | 16.13 | -0.9806 | -0.9806 | 0.5312 | 0.8194 | 0.3489 | -- | 15.07 | -- | -64.75 | -- | -75.91 | -- | -- | -- | -185.59 | -- | -- | -- | 0.00 | -- | 2,380.00 | -- | -31.39 | -- | -- | -- |
| Active Biotech AB publ | 0.00 | -56.37m | 250.04m | 11.00 | -- | 12.90 | -- | -- | -0.2525 | -0.2525 | 0.00 | 0.0744 | 0.00 | -- | -- | -- | -99.01 | -27.85 | -119.68 | -56.59 | -- | -- | -- | -472.29 | -- | -76.42 | 0.2212 | -- | -100.00 | -- | -54.52 | -- | -- | -- |
| Magle Chemoswed Holding AB | 131.64m | 8.97m | 252.74m | -- | 28.19 | 1.75 | 11.76 | 1.92 | 0.8444 | 0.8444 | 12.40 | 13.61 | 0.5728 | 0.5777 | 5.97 | -- | 3.90 | -- | 5.06 | -- | 89.35 | -- | 6.81 | -- | 0.7295 | -- | 0.2557 | -- | -7.16 | -- | 130.57 | -- | -- | -- |
| SoftOx Solutions AS | 6.22m | -66.47m | 269.95m | -- | -- | 4.15 | -- | 43.40 | -6.68 | -6.68 | 0.618 | 6.29 | 0.0732 | -- | 0.4637 | -- | -78.20 | -44.89 | -95.77 | -54.35 | -- | -- | -1,068.77 | -540.76 | 1.08 | -116.25 | 0.1873 | -- | -19.69 | 139.15 | -74.85 | -- | -- | -- |
| Kancera AB | 0.00 | -50.66m | 276.58m | 7.00 | -- | 2.96 | -- | -- | -0.918 | -0.918 | 0.00 | 1.69 | 0.00 | -- | -- | 0.00 | -39.19 | -68.54 | -43.09 | -86.44 | -- | 92.88 | -- | -5,941.59 | -- | -115.85 | 0.00 | -- | -100.00 | -- | -12.80 | -- | -- | -- |
| ISR Immune System Rgultn Hldg AB (publ) | 0.00 | -252.86m | 278.20m | -- | -- | -- | -- | -- | -3.65 | -3.65 | 0.00 | -2.39 | 0.00 | -- | -- | -- | -1,169.75 | -111.37 | -- | -155.17 | -- | -- | -- | -- | -- | -128,581.00 | -- | -- | -- | -- | -152.98 | -- | -- | -- |
| Arctic Bioscience AS | 23.95m | -36.30m | 281.54m | -- | -- | 0.919 | -- | 11.76 | -1.50 | -1.50 | 0.9861 | 12.57 | 0.0691 | 0.6235 | 2.68 | -- | -10.47 | -- | -11.05 | -- | 18.34 | -- | -151.56 | -- | 8.86 | -135.40 | 0.00 | -- | 4.97 | -- | -88.48 | -- | -- | -- |
| Alligator Bioscience AB | 18.76m | -160.10m | 285.43m | 49.00 | -- | 1.51 | -- | 15.22 | -1.27 | -1.27 | 0.1245 | 0.8722 | 0.0938 | -- | 2.35 | 414,673.90 | -80.03 | -33.26 | -98.19 | -36.20 | -- | -- | -853.59 | -672.07 | -- | -- | 0.0967 | -- | 197.40 | -25.98 | 1.09 | -- | -58.36 | -- |
| SenzaGen AB | 29.82m | -30.42m | 286.32m | 16.00 | -- | 2.97 | -- | 9.60 | -1.26 | -1.26 | 1.24 | 4.07 | 0.2841 | 4.46 | 5.66 | -- | -28.98 | -25.56 | -32.24 | -27.47 | 63.32 | 130.22 | -102.02 | -471.45 | 3.51 | -- | 0.0092 | -- | 93.79 | 98.69 | -15.38 | -- | -23.45 | -- |
| Herantis Pharma Oyj | 0.00 | -111.88m | 330.44m | -- | -- | 16.13 | -- | -- | -0.8301 | -0.8301 | 0.00 | 0.1135 | 0.00 | -- | -- | -- | -110.52 | -65.71 | -198.51 | -79.09 | -- | -- | -- | -- | -- | -6.65 | 0.7896 | -- | -- | -- | -39.49 | -- | -- | -- |
| Vo2 Cap Holding AB (publ) | 371.22m | -5.24m | 335.22m | -- | -- | 1.92 | 49.22 | 0.903 | -0.323 | -0.323 | 9.09 | 3.61 | 1.93 | -- | 12.51 | -- | -2.72 | -31.87 | -3.80 | -57.95 | 21.37 | 26.64 | -1.41 | -19.29 | -- | 5.26 | 0.1680 | -- | 46,310.78 | 185.46 | -246.86 | -- | -- | -- |
| Initiator Pharma A/S | 0.00 | -61.40m | 358.37m | -- | -- | 11.99 | -- | -- | -1.40 | -1.40 | 0.00 | 0.5816 | 0.00 | -- | -- | -- | -124.45 | -70.46 | -139.58 | -80.40 | -- | -- | -- | -- | -- | -- | 0.4185 | -- | -- | -- | -142.20 | -- | -- | -- |
| Mendus AB (publ) | 1.76m | -114.66m | 362.33m | 34.00 | -- | 0.6138 | -- | 205.40 | -0.5836 | -0.5836 | 0.009 | 3.01 | 0.0025 | -- | 0.0943 | 59,800.00 | -16.00 | -23.81 | -16.48 | -26.35 | -- | -- | -6,499.94 | -- | -- | -31.27 | 0.0418 | -- | -- | -- | -49.48 | -- | -- | -- |
Data as of Oct 03 2022. Currency figures normalised to Arctic Bioscience AS's reporting currency: Norwegian Krone NOK
9.91%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fj�rde AP-fondenas of 30 Jun 2022 | 1.20m | 4.92% |
| Storebrand Asset Management ASas of 31 May 2022 | 1.02m | 4.17% |
| Cicero Fonder ABas of 31 Aug 2022 | 113.32k | 0.47% |
| Equinor Asset Management ASAas of 30 Jun 2022 | 85.00k | 0.35% |
More ▼
Data from 30 Jun 2022 - 31 Aug 2022Source: FactSet Research Systems Inc.
